Among the gynecologic malignancies, epithelial ovarian tumors are the leading cause of death. For the past few decades, the only treatment has involved surgical resection of the tumor and/or general chemotherapies. In an attempt to improve treatment options, we have shown that several oncogenes that are overexpressed in ovarian cancer, PI3K, PKCiota, and cyclin E, all of which have been shown to lead to a poor prognosis and decreased survival, converge into a single pathway that could potentially be targeted therapeutically. Because of the ability of either PKCiota or cyclin E overexpression to independently induce anchorage-independent growth, a hallmark of cancer, we hypothesized that targeting PKCiota expression in ovarian cancer cells c...
E-cadherin is a cell-cell adhesion protein and tumor suppressor that is silenced in many malignancie...
Background: The role of estrogen in the growth and survival of ovarian cancer cells is controversial...
Ovarian cancer is the fifth most common cause of death due to cancer in women despite being the tent...
We show that atypical PKCiota, which plays a critical role in the establishment and maintenance of e...
Protein kinase Ci (PKCi) has oncogenic potential and is an attractive therapeutic target for treatme...
We show that atypical PKCι, which plays a critical role in the establishment and maintenance of epit...
Cyclin E1 (CCNE1) gene amplification occurs in approximately 20% of ovarian high grade serous carcin...
Epithelial Ovarian Cancer (EOC) is the leading cause of cancer related death associated with gynecol...
Chemoresistance remains a major clinical obstacle to effective management of ovarian cancer. Cancer ...
Purpose: There is a lack of prognostic and predictive biomarkers in epithelial ovarian carcinoma, an...
Research has demonstrated that the atypical protein kinase C-zeta (PKC-ζ) is a component of many dys...
Background: The objective of this study was to determine whether cyclin E overexpression defines an ...
In spite of the clinical importance of epithelial ovarian cancer (EOC), little is known about the pa...
Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is large...
PURPOSE: Amplification of cyclin E1 (CCNE1) is associated with poor outcome in breast, lung, and oth...
E-cadherin is a cell-cell adhesion protein and tumor suppressor that is silenced in many malignancie...
Background: The role of estrogen in the growth and survival of ovarian cancer cells is controversial...
Ovarian cancer is the fifth most common cause of death due to cancer in women despite being the tent...
We show that atypical PKCiota, which plays a critical role in the establishment and maintenance of e...
Protein kinase Ci (PKCi) has oncogenic potential and is an attractive therapeutic target for treatme...
We show that atypical PKCι, which plays a critical role in the establishment and maintenance of epit...
Cyclin E1 (CCNE1) gene amplification occurs in approximately 20% of ovarian high grade serous carcin...
Epithelial Ovarian Cancer (EOC) is the leading cause of cancer related death associated with gynecol...
Chemoresistance remains a major clinical obstacle to effective management of ovarian cancer. Cancer ...
Purpose: There is a lack of prognostic and predictive biomarkers in epithelial ovarian carcinoma, an...
Research has demonstrated that the atypical protein kinase C-zeta (PKC-ζ) is a component of many dys...
Background: The objective of this study was to determine whether cyclin E overexpression defines an ...
In spite of the clinical importance of epithelial ovarian cancer (EOC), little is known about the pa...
Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is large...
PURPOSE: Amplification of cyclin E1 (CCNE1) is associated with poor outcome in breast, lung, and oth...
E-cadherin is a cell-cell adhesion protein and tumor suppressor that is silenced in many malignancie...
Background: The role of estrogen in the growth and survival of ovarian cancer cells is controversial...
Ovarian cancer is the fifth most common cause of death due to cancer in women despite being the tent...